Paris-based company developing an innovative treatment for patients living with chronic mucosal inflammatory diseases
Thabor Therapeutics has raised €2.0M across 1 funding round from 1 investor, most recently a round in Jul 2022. Based in Paris, France; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-07-06 | Other |
| €2.0M |
| Bpifrance |
| View deal → |
